Evidence map›Paper›PMID 25892152›Full record

ArticleGeneral hospital psychiatry

Psychiatric comorbidity in depressed HIV-infected individuals: common and clinically consequential.

Bradley N Gaynes, Julie O'Donnell, Elise Nelson, Amy Heine, Anne Zinski, Malaika Edwards, Teena McGuinness, Modi A Riddhi, Charita Montgomery, Brian W Pence

Abstract read
In one paragraph

Article in General hospital psychiatry. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 2 pooled it
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 2 syntheses or guidelines pooled it, 46 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Bradley N GaynesDepartment of Psychiatry, University of North Carolina School of Medicine, Chapel Hill, NC. Electronic address: bgaynes@med.unc.edu.
Julie O'DonnellDepartment of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC. Electronic address: jkodonne@email.unc.edu.
Elise NelsonCenter for Health Policy and Inequalities Research, Duke University, Durham, NC. Electronic address: elise.nelson@duke.edu.
Amy HeineDivision of Infectious Diseases, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC. Electronic address: amy_heine@med.unc.edu.
Anne ZinskiDivision of Infectious Diseases, University of Alabama at Birmingham School of Medicine, Birmingham, AL. Electronic address: azinski@uab.edu.
Malaika EdwardsInfectious Diseases Clinic, Institute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC. Electronic address: malaika_edwards@med.unc.edu.
Teena McGuinnessSchool of Nursing, University of Alabama at Birmingham, Birmingham, AL. Electronic address: tmcg@uab.edu.
Modi A RiddhiDepartment of Medicine, University of Alabama at Birmingham, Birmingham, AL. Electronic address: rmodi@uab.edu.
Charita MontgomeryInfectious Diseases Clinic, Institute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC. Electronic address: charita_montgomery@med.unc.edu.
Brian W PenceDepartment of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC. Electronic address: bpence@unc.edu.
University of North Carolina at Chapel Hill · USUniversity of Alabama at Birmingham · USDuke University · US

Funding

Virology CoreP30AI027767 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI OLAF KUTSCH · 1988 to 2026
$84.1M
Virology, Immunology, and Microbiology CoreP30AI050410 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAVID M. MARGOLIS · 2001 to 2026
$76.9M
Social and Behavioral Sciences CoreP30AI064518 · NIAID · DUKE UNIVERSITY · PI Nwora Lance Okeke · 2005 to 2026
$50.5M
Training in Infectious Disease Epidemiology (TIDE)T32AI070114 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Brian W Pence · 2007 to 2026
$4.0M
Improving HAART Adherence in Depressed HIV Clinic Patients: A Real-World RCTR01MH086362 · NIMH · DUKE UNIVERSITY · PI PENCE, BRIAN W · 2009 to 2013
$3.5M
NIAID NIH HHS P30 AI027767NIAID NIH HHS P30-AI027767NIAID NIH HHS P30 AI050410NIAID NIH HHS P30 AI064518NIAID NIH HHS P30-AI064518NIAID NIH HHS P30-AI50410NIAID NIH HHS T32 AI070114NIMH NIH HHS R01 MH086362NIMH NIH HHS R01MH086362
6 · The paper itself

Abstract

objectiveTo report on the prevalence of psychiatric comorbidity and its association with illness severity in depressed HIV patients.

methodsAs part of a multi-site randomized controlled trial of depression treatment for HIV patients, 304 participants meeting criteria for current Major Depressive Disorder (MDD) were assessed for other mood, anxiety and substance use disorders with the Mini-International Neuropsychiatric Interview, a structured psychiatric diagnostic interview. We also assessed baseline adherence, risk, and health measures.

resultsComplicated depressive illness was common. Only 18% of participants experienced MDD with no comorbid psychiatric diagnoses; 49% had comorbid dysthymia, 62% had ≥1 comorbid anxiety disorder, and 28% had a comorbid substance use disorder. Self-reported antiretroviral adherence did not differ by the presence of psychiatric comorbidity. However, psychiatric comorbidity was associated with worse physical health and functioning: compared to those with MDD alone, individuals with ≥1 comorbidity reported more HIV symptoms (5.1 vs. 4.1, P=.01), and worse mental health-related quality of life on the SF-12 (29 vs. 35, P<.01).

conclusionFor HIV patients with MDD, chronic depression and psychiatric comorbidity are strikingly common, and this complexity is associated with greater HIV disease severity and worse quality of life. Appreciating this comorbidity can help clinicians better target those at risk of harder-to-treat HIV disease, and underscores the challenge of treating depression in this population.

Indexed as

AdultAnti-Retroviral AgentsAnxiety DisordersComorbidityDrug MonitoringDysthymic DisorderFemaleHIV InfectionsHumansMajor Depressive DisorderMaleMedication AdherenceMiddle AgedPrevalenceQuality of LifeSubstance-Related DisordersAnti-Retroviral AgentsDepressionHIVPsychiatric comorbidityQuality of life

Identifiers

PMID25892152
PMCPMC4457699
OpenAlexW2013095288

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.